Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1926 1
1932 2
1933 1
1934 2
1940 1
1941 1
1942 1
1945 1
1946 1
1947 2
1948 1
1949 5
1951 3
1952 3
1953 2
1954 2
1955 3
1956 4
1957 3
1958 2
1959 2
1960 5
1961 1
1962 2
1963 5
1964 3
1965 6
1966 3
1967 3
1968 6
1969 11
1970 13
1971 13
1972 7
1973 13
1974 18
1975 19
1976 17
1977 14
1978 20
1979 25
1980 20
1981 27
1982 33
1983 20
1984 24
1985 37
1986 33
1987 28
1988 32
1989 25
1990 32
1991 32
1992 27
1993 18
1994 30
1995 40
1996 29
1997 42
1998 39
1999 44
2000 44
2001 34
2002 40
2003 65
2004 51
2005 74
2006 79
2007 68
2008 106
2009 78
2010 86
2011 66
2012 73
2013 91
2014 80
2015 90
2016 84
2017 76
2018 102
2019 110
2020 111
2021 137
2022 156
2023 148
2024 42

Text availability

Article attribute

Article type

Publication date

Search Results

2,711 results

Results by year

Filters applied: . Clear all
Page 1
Alzheimer’s Disease: Etiology, Neuropathology and Pathogenesis.
Sheppard O, Coleman M. Sheppard O, et al. Among authors: coleman m. In: Huang X, editor. Alzheimer’s Disease: Drug Discovery [Internet]. Brisbane (AU): Exon Publications; 2020 Dec 18. Chapter 1. In: Huang X, editor. Alzheimer’s Disease: Drug Discovery [Internet]. Brisbane (AU): Exon Publications; 2020 Dec 18. Chapter 1. PMID: 33400468 Free Books & Documents. Review.
Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion.
Jiang N, Xie B, Xiao W, Fan M, Xu S, Duan Y, Hamsafar Y, Evans AC, Huang J, Zhou W, Lin X, Ye N, Wanggou S, Chen W, Jing D, Fragoso RC, Dugger BN, Wilson PF, Coleman MA, Xia S, Li X, Sun LQ, Monjazeb AM, Wang A, Murphy WJ, Kung HJ, Lam KS, Chen HW, Li JJ. Jiang N, et al. Among authors: coleman ma. Nat Commun. 2022 Mar 21;13(1):1511. doi: 10.1038/s41467-022-29137-3. Nat Commun. 2022. PMID: 35314680 Free PMC article.
The MAGNOLIA Trial: Zanubrutinib, a Next-Generation Bruton Tyrosine Kinase Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Marginal Zone Lymphoma.
Opat S, Tedeschi A, Linton K, McKay P, Hu B, Chan H, Jin J, Sobieraj-Teague M, Zinzani PL, Coleman M, Thieblemont C, Browett P, Ke X, Sun M, Marcus R, Portell CA, Ardeshna K, Bijou F, Walker P, Hawkes EA, Mapp S, Ho SJ, Talaulikar D, Zhou KS, Co M, Li X, Zhou W, Cappellini M, Tankersley C, Huang J, Trotman J. Opat S, et al. Among authors: coleman m. Clin Cancer Res. 2021 Dec 1;27(23):6323-6332. doi: 10.1158/1078-0432.CCR-21-1704. Epub 2021 Sep 15. Clin Cancer Res. 2021. PMID: 34526366 Free PMC article.
Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors.
Stalnecker CA, Grover KR, Edwards AC, Coleman MF, Yang R, DeLiberty JM, Papke B, Goodwin CM, Pierobon M, Petricoin EF, Gautam P, Wennerberg K, Cox AD, Der CJ, Hursting SD, Bryant KL. Stalnecker CA, et al. Among authors: coleman mf. Cancer Res. 2022 Feb 15;82(4):586-598. doi: 10.1158/0008-5472.CAN-21-1443. Cancer Res. 2022. PMID: 34921013 Free PMC article.
Phase II study of acalabrutinib in ibrutinib-intolerant patients with relapsed/refractory chronic lymphocytic leukemia.
Rogers KA, Thompson PA, Allan JN, Coleman M, Sharman JP, Cheson BD, Jones D, Izumi R, Frigault MM, Quah C, Raman RK, Patel P, Wang MH, Kipps TJ. Rogers KA, et al. Among authors: coleman m. Haematologica. 2021 Sep 1;106(9):2364-2373. doi: 10.3324/haematol.2020.272500. Haematologica. 2021. PMID: 33730844 Free PMC article. Clinical Trial.
2,711 results